Table 3 Complication rates reported in different studies and rates found in this study
Omar et al | Nagraj et al. a | Bamigbola et al.b | Erdogan et al | Askapour et al | Javaid Et al | Chu et al. c | Control group | Group A | Group Bd | |
|---|---|---|---|---|---|---|---|---|---|---|
Year | 2004 | 2006 | 2012 | 2013 | 2013 | 2018 | 2019 | 2021 | 2017–2018 | 2019 |
Country | Libya | UK | Nigeria | Turkey | Iran | Pakistan | China | Spain | Eq. Guinea | Eq. Guinea |
Number of patients | 827 | 125 | 41 | 3776 | 269 | 241 | 3006 | 188 | 94 | 62 |
Complication rate | 6.6% | 18.4% | 24.4% | 12% | 5.2% | 17.01% | 1.4% | 5.8% | 21.3% | 11.2% |
SSI | 1.9% | 2.3% | 14.4% | 0.6% | 0.4% | 0% | 0.3% | 0.5% | 7.5% | 1.6% |